Fulgent Genetics Inc. (FLGT)
FLGT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$21.06
-1.91% on the day
Market cap
$579.5M
Small cap
Revenue · 2025
$322.7M
+13.8% on 2024
Net income · 2025
-$60.5M
-18.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | FLGT on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001674930 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $322.7M |
| Net income | -$60.5M |
| Operating income | -$91.1M |
| Net margin | -18.8% |
| Operating margin | -28.2% |
| Revenue growth | +13.8% |
| Cash | $50.2M |
| Total assets | $1.2B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2020-11-20 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-07-30 |
| Latest proxy | DEFA14A | 2026-03-31 |
Source: SEC EDGAR submissions feed, 665 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.3% |
| 1 month | -1.1% |
| 3 months | +2.4% |
| Year to date | -19.9% |
| 1 year | -6.4% |
| From 52-week high | -31.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| YDES | YD Bio Limited | $6.10 | -3.63% | $432.1M |
| CSTL | Castle Biosciences Inc. | $32.88 | +0.37% | $1.0B |
| LMRI | Lumexa Imaging Holdings Inc. | $10.61 | -0.66% | $1.0B |
| TRUP | Trupanion Inc. | $26.57 | +1.06% | $1.2B |
| BDSX | Biodesix Inc. | $25.00 | -2.72% | $263.8M |
| FRNM | Freenome Inc. | $12.64 | -4.39% | $1.4B |
| TLSI | TriSalus Life Sciences Inc. | $4.00 | -3.38% | $246.3M |
| XGN | Exagen Inc. | $8.48 | +2.79% | $205.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier